CM
SRPT icon

Castleark Management’s Sarepta Therapeutics SRPT Stock Holding History

Castleark Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,340
Closed -$417K – 327
2024
Q3 		$417K Sell
3,340
-400
-11% -$55.3K 0.02% 220
2024
Q2 		$591K Buy
3,740
+1,390
+59% +$179K 0.02% 221
2024
Q1 		$304K Buy
+2,350
New +$288K 0.01% 241
2023
Q1 		– Sell
-41,440
Closed -$5.37M – 320
2022
Q4 		$5.37M Sell
41,440
-9,530
-19% -$1.1M 0.28% 90
2022
Q3 		$5.63M Buy
+50,970
New +$5.14M 0.31% 72
2021
Q1 		– Sell
-7,945
Closed -$1.35M – 372
2020
Q4 		$1.35M Sell
7,945
-815
-9% -$121K 0.05% 217
2020
Q3 		$1.23M Buy
8,760
+3,050
+53% +$464K 0.05% 208
2020
Q2 		$916K Buy
+5,710
New +$777K 0.04% 214
2019
Q2 		– Sell
-11,210
Closed -$1.34M – 393
2019
Q1 		$1.34M Sell
11,210
-220
-2% -$28.3K 0.05% 247
2018
Q4 		$1.25M Sell
11,430
-69,875
-86% -$8.74M 0.05% 253
2018
Q3 		$13.1M Buy
81,305
+11,835
+17% +$1.62M 0.38% 90
2018
Q2 		$9.18M Sell
69,470
-33,708
-33% -$3.18M 0.28% 117
2018
Q1 		$7.64M Sell
103,178
-179,632
-64% -$12M 0.24% 132
2017
Q4 		$15.7M Sell
282,810
-1,220
-0.4% -$64.6K 0.47% 62
2017
Q3 		$12.9M Buy
+284,030
New +$11.4M 0.4% 79

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Castleark Management's SRPT Position: Q4 2024 in Review

Castleark Management sold out of Sarepta Therapeutics (SRPT) in Q4 2024, closing a stake of 3,340 shares — an estimated $417K sold.

Castleark Management first reported a position in SRPT in Q3 2017 and held it in 15 quarters. The position peaked at $15.7M in Q4 2017. 464 funds tracked by Wall St. Rank hold SRPT as of Q4 2024.

  • Castleark Management reported no remaining Sarepta Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Castleark Management sold 3,340 Sarepta Therapeutics shares in Q4 2024, an estimated $417K.
  • Castleark Management first reported a position in Sarepta Therapeutics in Q3 2017 and held it in 15 quarters.
  • Castleark Management's Sarepta Therapeutics position peaked at $15.7M in Q4 2017.
  • 464 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2024.

Based on Castleark Management's 13F filing for Q4 2024, filed 18 Feb 2025.